-
Mashup Score: 2Managing infections with novel immunotherapies: Prevention, treatment, and impact on the QoL of patients with MM - 2 year(s) ago
During the 18th International Myeloma Workshop, the Multiple Myeloma Hub spoke with Michel Delforge, UCLouvain, Louvain-la-Neuve, BE and Noopur Raje, Massachusetts General Hospital, Boston, US. In this podcast, they discuss the topic: Managing infections with novel immunotherapies: Prevention, treatment, and impact on the quality of life of patients with multiple myeloma.
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Treatment-free intervals for patients with myeloma - 2 year(s) ago
Luciano Costa, MD, PhD, of the University of Alabama at Birmingham, Birmingham, AL, talks on whether it is possible to…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Should patients with #Myeloma be given treatment-free intervals? Luciano Costa (@End_myeloma) of @UABNews discusses both sides of the argument ⚖️ Watch here : 👉https://t.co/YEeumVehkX👈 @Myeloma_Society #IMW2021 #IMW21 #MultipleMyeloma #MMsm #HemOnc
-
-
Mashup Score: 0
VJHemOnc is excited to bring you the latest updates from 18th International Myeloma Workshop (IMW) 2021, which brought together leading experts to share the most recent and exciting new developments in the field of myeloma, covering areas including novel immunotherapies, CAR-T, MRD and more.
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Missed #IMW2021? Catch up with #VJToday! 👨⚕️👨⚕️ Heinz Ludwig and Hermann Einsele (@H_Einsele) discuss hot topics from IMW 2021 including long-term DFS, MRD and patient empowerment! 📰 Read all about it: https://t.co/TscC8Ix0wo @VJHemOnc #Myeloma #MMsm #MultipleMyeloma #HemOnc
-
-
Mashup Score: 7
VJHemOnc is excited to bring you the latest updates from 18th International Myeloma Workshop (IMW) 2021, which brought together leading experts to share the most recent and exciting new developments in the field of myeloma, covering areas including novel immunotherapies, CAR-T, MRD and more.
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#VJToday | Catch up on key updates from the #IMW2021 meeting with @mvmateos and @IreneGhobrial 👩⚕️👩⚕️ Including: 🔸 Smoldering myeloma 🔸 Screening precursor conditions 🔸 Novel therapies 📰 Read here 👉 https://t.co/bzfValhz5e @VJHemOnc #MMsm #Myeloma #MultipleMyeloma #HemOnc
-
-
Mashup Score: 0After the CARDAMON trial update, what do we know about the role of ASCT and K maintenance in NDMM? - 3 year(s) ago
During the 18th International Myeloma Workshop, the Multiple Myeloma Hub spoke with Rakesh Popat, UCL Hospitals NHS Foundation Trust, London, UK. We asked, After the CARDAMON trial update, what do we know about the role of autologous stem cell transplant and K maintenance in newly diagnosed multiple myeloma?
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📹 #IMW2021 | The @MM_Hub spoke with @DrRakeshPopat, @uclh. We asked, After the CARDAMON trial update, what do we know about the role of autologous stem cell transplant and K maintenance in newly diagnosed multiple #myeloma? 👇 #mmsm https://t.co/QGYphWNivn
-
-
Mashup Score: 2
VJHemOnc is excited to bring you the latest updates from 18th International Myeloma Workshop (IMW) 2021, which brought together leading experts to share the most recent and exciting new developments in the field of myeloma, covering areas including novel immunotherapies, CAR-T, MRD and more.
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Missed #IMW2021? Catch up with #VJToday! 👨⚕️👨⚕️ Heinz Ludwig and Hermann Einsele (@H_Einsele) discuss hot topics from IMW 2021 including long-term DFS, MRD and patient empowerment! 📰 Read all about it: https://t.co/5y7dBv0uFQ @VJHemOnc #Myeloma #MMsm #MultipleMyeloma #HemOnc
-
-
Mashup Score: 0The Multiple Myeloma Daily - 3 year(s) ago
A selection of articles, blog posts, videos and photos recommended by Robert Z. Orlowski
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet-
The latest The Multiple Myeloma Daily! https://t.co/mpnEqprfz9 Thanks to @Mohty_EBMT @myelomacrowd @BMS_Myeloma_US #myeloma #imw2021
-
-
Mashup Score: 4
We invite you to Post IMW a roundtable debate discussion with leading names in the field: • Prof. Nizar Bahlis • Prof. Luciano Costa • Prof. Jean Luc Harousseau • Prof. Shaji Kumar • Dr. Salomon Manier • Prof. María Victoria Mateos • Prof. Mohamad Mohty • Dr. Cyrille Touzeau • Prof. Saad Usmani
Source: Zoom Video CommunicationsCategories: Hem/Oncs, Latest HeadlinesTweet-
The post #IMW2021 roundtable discussion by @TheIACH @COMyCongress @NBahlis @End_myeloma @myelomaMD @mvmateos @szusmani , JL Harousseau, S Manier, C Touzeau. FREE registration at: https://t.co/58BrRiHnHb Not to be missed! https://t.co/4F20q9aCGw
-
-
Mashup Score: 3After the latest follow up of the MASTER trial, can we safely implement MRD-guided frontline treatment in the clinic? - 3 year(s) ago
During the 18th International Myeloma Workshop, the Multiple Myeloma Hub spoke with Luciano Costa, University of Alabama at Birmingham, Birmingham, US. We asked: After the latest follow-up of the MASTER trial, can we safely implement minimal residual disease (MRD)-guided frontline treatment in the clinic?
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📹 #IMW2021 | The @MM_Hub spoke with @End_myeloma, @UABNews. We asked: After the latest follow-up of the MASTER trial, can we safely implement minimal residual disease (MRD)-guided frontline treatment in the clinic? 👀 #mmsm #myeloma https://t.co/kJIDteyBVO
-
-
Mashup Score: 2OPTIMISMM: PVd for lenalidomide-refractory myeloma - 3 year(s) ago
Katja Weisel, MD, of the University Medical Center Hamburg-Eppendorf, Hamburg, Germany, shares updates from the OPTISMM trial (NCT01734928), a Phase…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#IMW2021 | OPTIMISMM: PVd for lenalidomide-refractory #Myeloma 📊Katja Weisel shares updates: https://t.co/NqyaP9kKqD @Myeloma_Society #IMW21 #MultipleMyeloma #MMsm #HemOnc #ImmunoOnc #CTSM #TrialUpdate
-
🎧 Listen to this #IMW2021 podcast! The @MM_Hub spoke with Michel Delforge, @UCLouvain_be and @NoopurRajeMD, @MGHCancerCenter. They discussed the topic: Managing infections with novel immunotherapies. #myeloma #mmsm https://t.co/gL97SPPPzS